Dr. Reddy's Laboratories (RDY) News Today $13.22 +0.51 (+3.97%) Closing price 03:59 PM EasternExtended Trading$13.20 -0.01 (-0.08%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Shelton Capital ManagementShelton Capital Management increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 401.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 87,350 shares of the company's stock after purchasing an additionalApril 11 at 6:19 AM | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Stock Holdings Increased by Wellington Management Group LLPWellington Management Group LLP boosted its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 431.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 896,165 shares of the company's stock after buying an additional 72April 11 at 4:21 AM | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Position Increased by Renaissance Technologies LLCRenaissance Technologies LLC raised its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 382.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 9,418,428 shares of the company's stock after buying an additional 7,467,979 shares duApril 10 at 7:11 AM | marketbeat.comDr. Reddy's Laboratories falls Wednesday, outperforms competitorsApril 9 at 4:43 PM | marketwatch.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA grew its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 587.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 318,875 sApril 9 at 5:02 AM | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Quadrant Capital Group LLCQuadrant Capital Group LLC raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 435.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 172,009 shares of the company's stoApril 8 at 5:55 AM | marketbeat.comGrantham Mayo Van Otterloo & Co. LLC Raises Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Grantham Mayo Van Otterloo & Co. LLC boosted its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 227.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 359,235 shares oApril 8 at 5:32 AM | marketbeat.comPrudential PLC Purchases New Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Prudential PLC acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 172,283 shares of the company's stock, valued at approximately $2,707,000. Several other larApril 8 at 5:04 AM | marketbeat.comJPMorgan Chase & Co. Acquires 2,313,987 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)JPMorgan Chase & Co. boosted its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 462.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,814,710 shares of the company's stock afteApril 8 at 3:36 AM | marketbeat.comSei Investments Co. Boosts Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Sei Investments Co. lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 399.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,625 shares of the company's stock afterApril 8 at 3:17 AM | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Hits New 12-Month Low - Should You Sell?Dr. Reddy's Laboratories (NYSE:RDY) Hits New 1-Year Low - What's Next?April 6, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Takes $1.84 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Integrated Quantitative Investments LLC bought a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 116,500 shares of the company's sApril 6, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Purchased by Pinpoint Asset Management LtdPinpoint Asset Management Ltd boosted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 12,206.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 476,875 shares of the company's stock after acquiring an additional 473,000April 6, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Schroder Investment Management GroupSchroder Investment Management Group increased its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 415.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 407,215 shares of thApril 6, 2025 | marketbeat.comPrudential Financial Inc. Boosts Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Prudential Financial Inc. raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 250.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 135,400 shares of the compApril 6, 2025 | marketbeat.comOrion Portfolio Solutions LLC Has $1.49 Million Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Orion Portfolio Solutions LLC increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 359.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 94,282 shares of the company's stock after buying an additional 73,758 shaApril 5, 2025 | marketbeat.comO Shaughnessy Asset Management LLC Increases Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)O Shaughnessy Asset Management LLC boosted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 260.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 248,844 shares of the company'April 4, 2025 | marketbeat.comAmerican Century Companies Inc. Has $13.62 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)American Century Companies Inc. lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 418.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 862,365 shares of the comApril 3, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by OLD Mission Capital LLCOLD Mission Capital LLC increased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 8,813.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,087,798 shares of the companyApril 2, 2025 | marketbeat.comAxiom Investors LLC DE Acquires 63,480 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Axiom Investors LLC DE raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 274.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 86,600 shares of the company's stock after acquiring an additional 63,480 shares duriApril 2, 2025 | marketbeat.comAIA Group Ltd Acquires 118,357 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)AIA Group Ltd lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 441.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 145,150 shares of the comApril 2, 2025 | marketbeat.comHighTower Advisors LLC Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)HighTower Advisors LLC purchased a new position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 29,922 shares of the company's stock,March 31, 2025 | marketbeat.comSegall Bryant & Hamill LLC Makes New Investment in Dr. Reddy's Laboratories Limited (NYSE:RDY)Segall Bryant & Hamill LLC bought a new stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 45,100 shares of the company's stock, valued at apprMarch 30, 2025 | marketbeat.comBio-Thera And Dr. Reddy's Partner To Launch Stelara And Simponi Biosimilars In Southeast AsiaMarch 29, 2025 | nasdaq.comBio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast AsiaMarch 27, 2025 | prnewswire.comDr. Reddy's Laboratories Limited (NYSE:RDY) Holdings Boosted by Natixis Advisors LLCNatixis Advisors LLC raised its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 422.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,166 shares of the company's stockMarch 27, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down - Here's What HappenedDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down - Time to Sell?March 26, 2025 | marketbeat.comGQG Partners LLC Purchases 1,571,808 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)GQG Partners LLC increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 359.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,008,759 shares of the company's stock after buyingMarch 26, 2025 | marketbeat.comSummit Global Investments Raises Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Summit Global Investments grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 404.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 141,902 shares of the company's stock after buying an additional 113,785 shares during the periMarch 24, 2025 | marketbeat.comCorient Private Wealth LLC Grows Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Corient Private Wealth LLC grew its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 447.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 157,338 shares of the company's stock afterMarch 24, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Purchased by Bank of New York Mellon CorpBank of New York Mellon Corp increased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 271.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,006 shares of the compMarch 24, 2025 | marketbeat.comAikya Investment Management Ltd Boosts Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Aikya Investment Management Ltd boosted its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 416.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,610,503 shares of the company's sMarch 22, 2025 | marketbeat.comEquities Analysts Issue Forecasts for RDY Q4 EarningsDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Research analysts at Zacks Research increased their Q4 2026 earnings per share estimates for Dr. Reddy's Laboratories in a report issued on Monday, March 17th. Zacks Research analyst R. Department now anticipates that the company will poMarch 21, 2025 | marketbeat.comParallel Advisors LLC Has $1.15 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Parallel Advisors LLC increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 399.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 72,790 shares of the company's stock after buying an addiMarch 21, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Purchased by Victory Capital Management Inc.Victory Capital Management Inc. increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 81,460 shares of the company's stMarch 20, 2025 | marketbeat.comPDS Planning Inc Boosts Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)PDS Planning Inc boosted its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 389.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,254 shares of the company's stock afteMarch 19, 2025 | marketbeat.comPNC Financial Services Group Inc. Increases Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)PNC Financial Services Group Inc. raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 404.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,644 shares of the company's sMarch 19, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What HappenedDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - What's Next?March 18, 2025 | marketbeat.comAlvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®March 18, 2025 | markets.businessinsider.comAlvotech and Dr. Reddy's Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®March 18, 2025 | businesswire.comSignaturefd LLC Has $2.19 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Signaturefd LLC grew its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 442.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 138,950 shares of the company's stock after buying an aMarch 18, 2025 | marketbeat.comAvantax Advisory Services Inc. Buys 90,193 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Avantax Advisory Services Inc. increased its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 396.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 112,935 shares of the company's stock after acquiring an additional 9March 18, 2025 | marketbeat.comAmundi Purchases 83,460 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Amundi grew its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 556.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 98,450 shares of the company's stock after acquiringMarch 18, 2025 | marketbeat.comFrank Rimerman Advisors LLC Grows Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Frank Rimerman Advisors LLC boosted its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 60.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 55,513 shares of the company's stock after buying aMarch 17, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Stake Boosted by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 96.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3March 17, 2025 | marketbeat.comSequoia Financial Advisors LLC Acquires 67,586 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Sequoia Financial Advisors LLC increased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 432.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 83,229 shares of the company's stock after purchasing an additiMarch 16, 2025 | marketbeat.comMondrian Investment Partners LTD Has $10.25 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Mondrian Investment Partners LTD boosted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 356.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 648,813 shares of the company's stock afterMarch 15, 2025 | marketbeat.comVestcor Inc Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Vestcor Inc raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 350.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 381,670 shares of the company's stock after purchasing an additional 296,993 shares during the perioMarch 15, 2025 | marketbeat.comJohnson Investment Counsel Inc. Boosts Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Johnson Investment Counsel Inc. boosted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 24,760 shares of the company's stock after buying an additional 19,March 14, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Reaches New 52-Week Low - Here's What HappenedDr. Reddy's Laboratories (NYSE:RDY) Hits New 52-Week Low - Here's What HappenedMarch 13, 2025 | marketbeat.com Remove Ads Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼1.180.93▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼164▲RDY Articles Average Week Remove Ads Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Intra-Cellular Therapies News Summit Therapeutics News Genmab A/S News Moderna News Viatris News Qiagen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.